ProShare Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

ProShare Advisors’s Portfolio CSLT Stock Details CSLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26,940	Closed	-$42K	–	2347
2021 Q4	$42K	Buy	26,940 +11,361	+73%	+$18.7K	﹤0.01%	2301
2021 Q3	$24K	Sell	15,579 -15,404	-50%	-$30.2K	﹤0.01%	1998
2021 Q2	$81K	Buy	+30,983	New	+$57.7K	﹤0.01%	2317
2020 Q1	–	Sell	-13,819	Closed	-$18K	–	1703
2019 Q4	$18K	Buy	13,819 +2,208	+19%	+$3.08K	﹤0.01%	1781
2019 Q3	$16K	Buy	+11,611	New	+$23.1K	﹤0.01%	1646
2018 Q3	–	Sell	-10,141	Closed	-$43K	–	1811
2018 Q2	$43K	Buy	+10,141	New	+$38.1K	﹤0.01%	1761

ProShare Advisors's CSLT Position: Q1 2022 in Review

ProShare Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 26,940 shares — an estimated $42K sold.

ProShare Advisors first reported a position in CSLT in Q2 2018 and held it in 6 quarters. The position peaked at $81K in Q2 2021. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

ProShare Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
ProShare Advisors sold 26,940 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $42K.
ProShare Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2018 and held it in 6 quarters.
ProShare Advisors's CASTLIGHT HEALTH, INC. position peaked at $81K in Q2 2021.
0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.